Table 1.

Baseline data of the women participating in the follow-up study

CharacteristicsStudy cohort
Median age (range)26.72 (15-76)
Patient category854
    Screening patient435 (50.9%)
    STD patient246 (28.8%)
    Gynecologic patient173 (20.3%)
Pap smear status850
    Pap class 1307 (35.9%)
    Pap class ≥2543 (63.6%)
Biopsy status359
    Normal121 (33.7%)
    NCIN100 (27.9%)
    CIN I90 (25.1%)
    CIN II48 (13.4%)
HC2 result850
    HPV positive604 (71.1%)
    HPV negative246 (28.9%)
Taqman result812
    High-risk HPV positive394 (48.5%)
    High-risk HPV negative418 (51.5%)
High-risk HPV prevalence812
    HPV16134 (16.5%)
    HPV18/4551 (6.3%)
    HPV3139 (4.8%)
    HPV33/52/5850 (6.2%)
    HPV351 (0.1%)
    HPV3915 (1.8%)
    Multiple type infections104 (12.8%)
Smoking status780
    Regular smoker214 (27.4%)
    Ex-smoker104 (13.3%)
    Nonsmoker462 (59.2%)
Sexual partners' smoking status744
    Smoker438 (58.9%)
    Nonsmoker306 (41.1%)
Pregnancy history791
    Yes553 (69.9%)
    No238 (30.1%)
No. deliveries783
    0370 (47.3%)
    1250 (31.9%)
    2141 (18.0%)
    ≥322 (2.8%)
Abortion history760
    Yes403 (47.2%)
    No357 (41.8%)
Onset of sexual activity, median (range)18.0 (13-35)
Partners during past 2 y, median (range)1.0 (0-30)
Mode of contraception762
    No contraception346 (45.4%)
    Hormonal130 (17.1%)
    Condom204 (26.8%)
    IUD53 (7.0%)
    Sterilization2 (0.3%)
    Other27 (3.5%)
Venereal disease history778
    Yes126 (16.2%)
    No652 (83.8%)
Casual sexual partners764
    Yes122 (16.0%)
    No642 (84.0%)
  • Abbreviations: STD, sexually transmitted disease; IUD, intrauterine device.